Daily Archives: April 22, 2020
NIH COVID-19 Treatment Guidelines
22 Apr, 2020 | 09:02h | UTCNIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health
News Release: Expert U.S. panel develops NIH treatment guidelines for COVID-19
Commentary: New U.S. Treatment Guidelines for Covid-19 Don’t See Much Progress – The New York Times
Antibody Surveys Suggesting Vast Undercount of Coronavirus Infections may be Unreliable
22 Apr, 2020 | 08:57h | UTCAntibody surveys suggesting vast undercount of coronavirus infections may be unreliable – Science
Wed April 22 – 10 Stories of The Day!
22 Apr, 2020 | 09:05h | UTC
1 – NIH Coronavirus Disease 2019 (COVID-19)
Treatment Guidelines – National Institutes of Health
News Release: Expert U.S. panel develops NIH treatment guidelines for COVID-19
Commentary: New U.S. Treatment Guidelines for Covid-19 Don’t See Much Progress – The New York Times
Commentaries: Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 – CNN AND More deaths, no benefit from malaria drug in VA virus study – Associated Press
8 – Richard Lehman’s covid-19 reviews, 20 April 2020 – The BMJ Opinion
“In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19”.
9 – Editorial: Modelling the pandemic – The BMJ
Related: Predictive Mathematical Models of the COVID-19 Pandemic (other commentaries on the subject)
“Over-reliance on modelling leads to missteps and blind spots in our response”
10 – Coronavirus Disease (COVID-19) Updates / 22 April 2020 Edition
22 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)
[Preprint] Observational Study: No Benefit from Hydroxychloroquine in Patients Hospitalized with Covid-19
22 Apr, 2020 | 08:58h | UTCOutcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19 – medRxiv
Commentaries: Study finds no benefit, higher death rate in patients taking hydroxychloroquine for Covid-19 – CNN AND More deaths, no benefit from malaria drug in VA virus study – Associated Press
ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic
22 Apr, 2020 | 09:00h | UTC
Evidence Review: Tests for Screening, Diagnosis and Monitoring of COVID-19
22 Apr, 2020 | 08:55h | UTC
Endocrinology in the Time of COVID-19: Management of Adrenal Insufficiency
22 Apr, 2020 | 08:52h | UTC
Study: SARS-CoV-2 Persists Longer in Stool and in Patients with Severe Disease
22 Apr, 2020 | 08:53h | UTC
COVID19 During Pregnancy: A Systematic Review of Reported Cases
22 Apr, 2020 | 08:43h | UTC
Richard Lehman’s Covid-19 Reviews—20 April 2020
22 Apr, 2020 | 08:50h | UTCRichard Lehman’s covid-19 reviews, 20 April 2020 – The BMJ Opinion
“In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19”.
Anesthesia and COVID-19: Infection Control
22 Apr, 2020 | 08:42h | UTCAnaesthesia and COVID-19: infection control – British Journal of Anaesthesia
WHO Guideline on Use of Ferritin to Assess Iron Status in Individuals and Populations
22 Apr, 2020 | 08:38h | UTCNews Release: WHO guidance helps detect iron deficiency and protect brain development
Editorial: Modelling the Pandemic
22 Apr, 2020 | 08:48h | UTCModelling the pandemic – The BMJ
Related: Predictive Mathematical Models of the COVID-19 Pandemic (other commentaries on the subject)
“Over-reliance on modelling leads to missteps and blind spots in our response”
Interview: The Epidemiologist Behind Sweden’s Controversial Coronavirus Strategy
22 Apr, 2020 | 08:46h | UTC
Guidance for Operative and Peri-Operative Care of Patients Infected by SARS-CoV-2
22 Apr, 2020 | 08:40h | UTC